Anavex Life Sciences Corp AVXL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:43 AM EDT
11.40quote price arrow up+0.60 (+5.56%)
Volume
219,753
52 week range
7.13 - 23.73
Loading...
  • Open11.13
  • Day High11.50
  • Day Low11.05
  • Prev Close10.80
  • 52 Week High23.73
  • 52 Week High Date11/08/21
  • 52 Week Low7.13
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap882.47M
  • Shares Out77.41M
  • 10 Day Average Volume0.81M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-34.41

KEY STATS

  • Open11.13
  • Day High11.50
  • Day Low11.05
  • Prev Close10.80
  • 52 Week High23.73
  • 52 Week High Date11/08/21
  • 52 Week Low7.13
  • 52 Week Low Date05/12/22
  • Market Cap882.47M
  • Shares Out77.41M
  • 10 Day Average Volume0.81M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-34.41

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-19.69
  • Fwd P/E (NTM)-16.36
  • EBITDA (TTM)-46.894M
  • ROE (TTM)-37.91%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/22/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anavex Life Sciences Corp

There is no recent news for this security.

Profile

MORE
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders. The Company’s lead compound ANAVEX2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by...
Christopher Missling Ph.D.
Chairman of the Board, President, Chief Executive Officer, Company Secretary
Sandra Boenisch CPA
Principal Financial Officer, Treasurer
Address
7TH FLOOR, 51 W 52ND STREET,
New York, NY
10019-6163
United States

Top Peers

SYMBOLLASTCHG%CHG
TGTX
TG Therapeutics Inc
7.76+0.32+4.30%
INBX
Inhibrx Inc
23.41-1.13-4.63%
CMPS
Compass Pathways PLC
19.23+0.29+1.53%
RNA
Avidity Biosciences Inc
19.34+0.02+0.10%
TIL
Instil Bio Inc
6.80+0.34+5.26%